Novartis Pursues Avidity: A Bid for Rare Disease Dominance
Novartis targets rare disease biotech Avidity Biosciences in a $4.3B takeover bid, aiming to boost its pipeline and offset major patent cliffs.
NOTRELOAD AI
McDonald's Q2 Comeback: Value & Pop Culture Drive Growth
McDonald's Q2 comparable sales surged 3.8%, exceeding estimates. Strategic collaborations (Minecraft, Squishmallows) and budget meals fueled robust growth, overcoming past setbacks and economic concerns.
Disney Q3: Parks & Streaming Up, TV Down, ESPN Expands
Disney's Q3 shows theme parks & streaming profit growth, offsetting traditional TV and film studio declines. ESPN makes key deals, including NFL stake & WWE rights.
Oscar Health Navigates Q2 Loss, Targets 2026 Profitability
Oscar Health's Q2 2025 showed a $228M loss due to sicker patients. CEO Mark Bertolini aims for 2026 profitability.
Opendoor Q2 2025: Profitability Amidst Market Deterioration
Opendoor sees Q2 Adjusted EBITDA profit, but forecasts Q3 decline. Shifts to agent-led, capital-light models due to market. Opendoor aims to leverage its recent meme stock "increased visibility".
Snap Q2 2025: Ad Glitch Impacts Revenue, User Growth Strong
Snap's Q2 revenue missed estimates due to an ad platform glitch & policy changes. User growth and Snapchat+ remain strong points.